PP2A-A alpha / β Antibodies

Santa Cruz Biotechnology features a diverse variety of PP2A-A alpha / β monoclonal antibodies for research focused on understanding protein phosphatase 2A (PP2A) in cellular processes. PP2A-A alpha / β Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PP2A is a key serine/threonine phosphatase involved in the regulation of numerous cellular functions, including cell growth, division, and apoptosis. Its dysregulation has been implicated in various diseases, including cancer, making PP2A-A alpha / β an important target for therapeutic intervention and biomarker discovery. Understanding the dynamics of PP2A activity is essential for elucidating its role in signaling pathways and disease mechanisms. PP2A-A alpha / β monoclonal antibodies enable precise detection and quantification of PP2A expression levels across different experimental conditions. Researchers can track PP2A localization within cells and tissues to better understand its distribution patterns. Advanced imaging techniques combined with PP2A-A alpha / β monoclonal antibodies allow visualization of protein interactions and modifications in real-time. Santa Cruz Biotechnology monoclonal antibodies for PP2A-A alpha / β support researchers worldwide in advancing our understanding of cellular regulation and disease mechanisms.